# US 2010/0305061 A1 · Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0305061 A1
- Document ID: US20100305061A1
- Status: Published application
- Kind: A1
- Application number: 12/744,738
- Filed: 2008-11-20
- Published: 2010-12-02
- Earliest claimed: 2007-11-27
- Assignees: Sigea S.R.L.
- Inventors: Marco Bosco; Luca Stucchi; Rita Gianni; Antonia Trevisan
- Web page: https://patentgrep.com/patent/US20100305061A1

## CPC

- C08B 37/0063: {Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan}
- A61K 8/73: Polysaccharides
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/10: Anti-acne agents
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61Q 19/08: Anti-ageing preparations
- C08B 37/0069: {Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof}
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- C08B 37/0075: {Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof}
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Disclosed are acid polysaccharides characterised by the concomitant presence of alcohol groups esterified with butyric and formic acids.

## Claims

### Claim 1

Acid polysaccharides characterised by the concomitant presence of alcohol groups esterified with butyric and formic acids.

### Claim 2 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the polysaccharide is a glycosaminoglycan.

### Claim 3 (depends on 2)

Acid polysaccharides as claimed in claim 2, wherein the glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin sulphate, dermatan sulphate, heparan sulphate and cheratan sulphate.

### Claim 4 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the carboxyl group is present in acid form or salified with alkali metals.

### Claim 5 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the molecular weight is selected from the range of between 103 and 107 daltons.

### Claim 6 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the polysaccharide is hyaluronic acid with a molecular weight of between 104 and 106 daltons.

### Claim 7 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the degree of esterification of butyric acid on the hydroxyl groups of the polymer is between 0.01 and 1*N, where N is the number of free alcohol groups present in the repetitive unit, while the degree of esterification of formic acid on the hydroxyl groups of the polymer is between 0.01 and 0.20.

### Claim 8 (depends on 1)

Acid polysaccharides as claimed in claim 1, wherein the degree of esterification of butyric acid on the hydroxyl groups of the polymer is between 0.01 and 0.2*N, where N is the number of free alcohol groups present in the repetitive unit, while the degree of esterification of formic acid on the hydroxyl groups of the polymer is between 0.01 and 0.20.

### Claim 9 (depends on 8)

Acid polysaccharides as claimed in claim 8, wherein the acid polysaccharide is hyaluronic acid, and wherein the degree of esterification of butyric acid on the hydroxyl groups of the polymer is between 0.01 and 0.8, while the degree of esterification of formic acid on the hydroxyl groups of the polymer is between 0.01 and 0.20.

### Claim 10 (depends on 1)

Process for the preparation of acid polysaccharides of claim 1, said process comprising:
a) dissolving the acid polysaccharide, salified with sodium or other alkali metals, in formamide by heating to obtain a solution;
b) adding butyric anhydride to the resulting solution, at room temperature, in the presence of an organic base to obtain a homogenous viscous reaction mixture;
c) diluting the homogenous, viscous reaction mixture with an aqueous solution of NaCl and neutralising it to pH 6-7.5;
d) purifying the dilute reaction mixture by dialysis or tangential filtration; and
e) freezing the purified polysaccharide solution and recovering the product by freeze-drying or spray-drying.

### Claim 11 (depends on 10)

Process as claimed in claim 10, wherein the organic base is an aromatic or aliphatic organic base comprising one atom of trisubstituted nitrogen.

### Claim 12 (depends on 10)

Process as claimed in claim 10, wherein the solubilisation temperature of polysaccharide in formamide is between 60° C. and 120° C.

### Claim 13 (depends on 1)

Process for the preparation of acid polysaccharides of claim 1, wherein the formate ester originates from hydrolysis of the formamide in the presence of butyric anhydride and a base.

### Claim 14 (depends on 1)

Topical compositions containing the acid polysaccharide derivatives of claim 1, and dermatologically acceptable inert carriers.

### Claim 15 (depends on 14)

Topical compositions as claimed in claim 14, including between 0.05% and 5% of polysaccharide acid by weight of the composition.

### Claim 16 (depends on 14)

Topical compositions as claimed in claim 14, selected from the group consisting of creams, ointments, gels, hydrophilic liquids, aqueous or water-alcohol lotions, oil/water or water/oil emulsions.

### Claim 17 (depends on 14)

A method of treatment of skin with moisturising, elasticising, skin-toning, anti-aging and anti-acne agents of claim 14 comprising applying said agents to patients in need thereof.

### Claim 18 (depends on 14)

A method for adjuvant treatment of skin lesions comprising applying the topical composition of claim 14 to patients in need thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein the skin lesions are inflammations, chronic ulcers, wounds, atopic or contact dermatitis, signs of aging or skin hyperthermia caused by radiation.

### Claim 20 (depends on 1)

Acid polysaccharides of claim 1, wherein the carboxyl group is salified with sodium.

### Claim 21 (depends on 10)

Process of claim 10, wherein the organic base is dimethylaminopyridine or triethylamine.

### Claim 22 (depends on 12)

Process of claim 12, wherein said temperature is 95° C.
